Skip to main content

Table 2 Changes in levels of cardiac function before and after four weeks treatment between the TEA group and control group

From: Effects of thoracic epidural analgesia on plasma cAMP and cGMP levels in patients with heart failure

GROUP LVEDD (mm) 95% CI EF (%) 95% CI FS (%) 95% CI NYHA 95% CI
Control group         
Pre-treatment 64.85 ± 5.86 (53.56-76.13) 32.45 ± 7.21 (18.31-46.59) 25.80 ± 5.73 (14.56-37.04) 3.65 ± 0.48 (2.69-4.61)
post-treatment 63.15 ± 5.23 (52.89-73.40) 33.15 ± 5.98 (21.44-44.86) 26.61 ± 5.52 (15.73-37.37) 3.3 ± 0.8 (1.73-4.87)
Chang 1.65 ± 0.64   0.55 ± 0.38   0.85 ± 0.61   0.35 ± 0.10  
TEA group         
Pre-treatment 66.45 ± 5.28 (56.08-76.80) 30.35 ± 6.78 (13.23-46.78) 24.20 ± 3.54 (17.24-31.15) 3.75 ± 0.44 (2.87-4.62)
post-treatment 58.30 ± 5.38 (47.75-68.64) 34.15 ± 6.12 (16.39-50.42) 28.15 ± 4.67 (18.99-37.30) 2.55 ± 0.76 (1.06-4.04)
Chang 8.15 ± 0.65**   3.80 ± 0.56**   3.95 ± 0.62**   1.2 ± 0.16**  
  1. Significant differences were performed using a two-tailed paired Student t test. (**: p<0.001, vs. control group).